Papers: 10.1172/JCI94516

https://doi.org/10.1172/JCI94516

JAK2/IDH-mutant–driven myeloproliferative neoplasm is sensitive to combined targeted inhibition

Cited by: 67
Author(s): Anna Sophia McKenney, Allison N. Lau, Amritha Varshini Hanasoge Somasundara, Barbara Spitzer, Andrew M. Intlekofer, Jihae Ahn, Kaitlyn Shank, Franck Rapaport, Minal Patel, Efthymia Papalexi, Alan H. Shih, April Chiu, Elizaveta Freinkman, Esra A. Akbay, Mya Steadman, Raj Nagaraja, Katharine Yen, Julie Teruya‐Feldstein, Kwok Kin Wong, Raajit K. Rampal, Matthew G. Vander Heiden, Craig B. Thompson, Ross L. Levine
Published: over 8 years ago

Software Mentions 2